Can Australia afford the costs of cardiology guidelines? True costs and strategies for reduction

Our analysis highlights the complex balance between efficacy, cost and equity in healthcare. We propose two practical strategies to address these challenges: embedding cost-effectiveness analyses into guideline formulation and promoting greater use of generic medications. Through these measures, we hope to prioritise cost-effective, evidence-based care and make it accessible to all Australians, while maintaining the long-term financial sustainability of the healthcare system.